Sangamo Therapeutics Inc SGMO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:47 PM EDT
0.67quote price arrow down-0.0037 (-0.5521%)
Volume
17,582
Close
0.6702quote price arrow up+0.0455 (+7.2835%)
Volume
1,230,935
52 week range
0.29 - 1.82
Loading...
  • Open0.625
  • Day High0.6734
  • Day Low0.62
  • Prev Close0.6247
  • 52 Week High1.82
  • 52 Week High Date03/30/23
  • 52 Week Low0.29
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap135.98M
  • Shares Out202.90M
  • 10 Day Average Volume2.81M
  • Dividend-
  • Dividend Yield-
  • Beta1.38
  • YTD % Change23.36

KEY STATS

  • Open0.625
  • Day High0.6734
  • Day Low0.62
  • Prev Close0.6247
  • 52 Week High1.82
  • 52 Week High Date03/30/23
  • 52 Week Low0.29
  • 52 Week Low Date11/13/23
  • Market Cap135.98M
  • Shares Out202.90M
  • 10 Day Average Volume2.81M
  • Dividend-
  • Dividend Yield-
  • Beta1.38
  • YTD % Change23.36

RATIOS/PROFITABILITY

  • EPS (TTM)-1.46
  • P/E (TTM)-0.46
  • Fwd P/E (NTM)-0.90
  • EBITDA (TTM)-87.527M
  • ROE (TTM)-136.47%
  • Revenue (TTM)176.232M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-146.30%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date04/24/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sangamo Therapeutics Inc

 

Profile

MORE
Sangamo Therapeutics, Inc. is a genomic medicines company that is developing medicines for neurological diseases. The Company's neurology preclinical development is focused on two areas: development of epigenetic regulation therapies to treat serious neurological diseases, and development of novel engineered adeno-associated virus (AAV) capsids to deliver its therapies to the intended neurological targets. The Company's zinc finger epigenetic regulators are ideally suited to...
H. Stewart Parker
Independent Chairman of the Board
Alexander Macrae Ph.D.
President, Chief Executive Officer, Director
Prathyusha Duraibabu CPA
Chief Financial Officer, Senior Vice President
Address
501 Canal Blvd.
Richmond, CA
94084
United States

Top Peers

SYMBOLLASTCHG%CHG
KPTI
Karyopharm Therapeutics Inc
1.51+0.03+2.03%
NSTGQ
NanoString Technologies Inc
0.08+0.01+14.2857%
STRO
Sutro Biopharma Inc
5.65+0.72+14.60%
AGEN
Agenus Inc
0.58+0.0236+4.2416%
XERS
Xeris Biopharma Holdings Inc
2.21+0.17+8.33%